These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 11354543

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Cytokines in rheumatoid arthritis: new therapeutic possibilities].
    Szekanecz Z, Szegedi G.
    Orv Hetil; 1998 Apr 05; 139(14):819-23. PubMed ID: 9569729
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA, Hu P, Epstein AL.
    Handb Exp Pharmacol; 2008 Apr 05; (181):291-328. PubMed ID: 18071951
    [Abstract] [Full Text] [Related]

  • 26. Tumor necrosis factor is not associated with intestinal ischemia/reperfusion-induced lung inflammation.
    Soares AL, Coelho FR, Guabiraba R, Kamal M, Vargaftig BB, Li L, Li J, Tavares-de-Lima W, Ryffel B.
    Shock; 2010 Sep 05; 34(3):306-13. PubMed ID: 20160673
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Immunological therapies for rheumatoid arthritis.
    Edwards CJ.
    Br Med Bull; 2005 Sep 05; 73-74():71-82. PubMed ID: 16174791
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. From cellular receptors to transduction-transcription pathways for cytokines: at which level should the inhibition be targeted in inflammation?
    Dayer JM, Molnarfi N, Burger D.
    Expert Opin Biol Ther; 2005 Sep 05; 5 Suppl 1():S83-96. PubMed ID: 16187943
    [Abstract] [Full Text] [Related]

  • 32. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F, Portela F.
    BioDrugs; 2010 Dec 14; 24 Suppl 1():3-14. PubMed ID: 21175228
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Biology of tumor necrosis factor-alpha- implications for psoriasis.
    Schottelius AJ, Moldawer LL, Dinarello CA, Asadullah K, Sterry W, Edwards CK.
    Exp Dermatol; 2004 Apr 14; 13(4):193-222. PubMed ID: 15086336
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Perspective of cytokine regulation for periodontal treatment: fibroblast biology.
    Takashiba S, Naruishi K, Murayama Y.
    J Periodontol; 2003 Jan 14; 74(1):103-10. PubMed ID: 12593604
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. TNF-alpha-induced chemokine production and apoptosis in human neural precursor cells.
    Sheng WS, Hu S, Ni HT, Rowen TN, Lokensgard JR, Peterson PK.
    J Leukoc Biol; 2005 Dec 14; 78(6):1233-41. PubMed ID: 16314440
    [Abstract] [Full Text] [Related]

  • 40. Therapeutic Monoclonal Antibodies for the Treatment of Chronic Obstructive Pulmonary Disease.
    Matera MG, Page C, Rogliani P, Calzetta L, Cazzola M.
    Drugs; 2016 Sep 14; 76(13):1257-1270. PubMed ID: 27506851
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.